Press Releases

April 25, 2018
Asklepios BioPharmaceutical, Inc. Announces Former Portfolio Company’s Preclinical Asset for Duchenne Muscular Dystrophy Has Advanced into the Clinic

December 14, 2017
Asklepios BioPharmaceutical, Inc. Launches New Portfolio Company – Actus Therapeutics, Inc.

October 17, 2017
AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen

September 26, 2017
NanoCor Announces New Data on Congestive Heart Failure Gene Therapy

August 1, 2016
Pfizer Acquires Bamboo Therapeutics

April 20, 2016
Nanocor Gets IND Acceptance for Carfostin

April 02, 2014
Baxter Acquires Chatham Therapeutics

September 13, 2010
Pfizer Licencces Hep C Technology from AskBIO

January 20, 2009
ALS Therapy Development Institute and AskBio Announce Collaboration Targeting Lou Gehrig Disease

September 10, 2007
Medtronic and NanoCor Form Partnership